Literature DB >> 31396763

Bills as Band-Aids: Hopes and Challenges of Expanding Pharmacists' Prescriptive Authority to Include Contraceptives.

Kathrine Bendtsen1.   

Abstract

This paper critically examines the implications of state efforts to expand prescriptive authority of pharmacists, which will allow them to prescribe various types of hormonal contraceptives. With this expansion, women no longer need to see a physician before being prescribed such contraceptives, but instead, they must answer self-assessment questionnaires at the pharmacy to ensure that their chosen method is safe and appropriate. This paper argues that while these measures to expand pharmacists' prescriptive authority will surely meet the stated goal to increase access to hormonal contraceptives, the measures may have detrimental consequences that have largely been downplayed. Studies consistently show that the OB-GYN is a significant primary care provider identified by young female patients, and some of the main reasons provided by these young women for going to the OB-GYN is to discuss, or obtain a prescription for, contraceptives. Through the expansion of pharmacists' prescriptive authority, a likely consequence is that some women will relinquish going to the OB-GYN. However, the OB-GYN provides important services beyond contraceptives, such as preventive screenings for hypertension, cardiovascular diseases, alcohol abuse, mental health, etc., and there is evidence supporting both the effectiveness and cost-benefits of these interventions. By increasing access to contraceptives, the likely result is that many women will have less interaction with a physician and will receive fewer preventive screenings. I do not wish to suggest that these bills should not pass, nor that OB-GYNs should hold contraceptives hostage, only that there are consequences to expanded prescriptive authority that must be anticipated. Further, expanding prescriptive authority obscures the real problem: some individuals have trouble accessing the health care system, not merely trouble accessing hormonal contraceptives. The expansion of prescriptive authority to include contraceptives applies a Band-Aid to treat one aspect of this problem. What is needed is not merely expanded access to hormonal contraceptives, but better access to health care in general.

Entities:  

Keywords:  Contraception; Pharmacists’ prescriptive authority; Women’s health

Mesh:

Substances:

Year:  2019        PMID: 31396763     DOI: 10.1007/s10730-019-09380-w

Source DB:  PubMed          Journal:  HEC Forum        ISSN: 0956-2737


  29 in total

1.  Unintended pregnancy in the United States: incidence and disparities, 2006.

Authors:  Lawrence B Finer; Mia R Zolna
Journal:  Contraception       Date:  2011-08-24       Impact factor: 3.375

2.  Actual causes of death in the United States.

Authors:  J M McGinnis; W H Foege
Journal:  JAMA       Date:  1993-11-10       Impact factor: 56.272

3.  Declines in Unintended Pregnancy in the United States, 2008-2011.

Authors:  Lawrence B Finer; Mia R Zolna
Journal:  N Engl J Med       Date:  2016-03-03       Impact factor: 91.245

4.  Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009.

Authors:  Jean Y Ko; Sherry L Farr; Patricia M Dietz; Cheryl L Robbins
Journal:  J Womens Health (Larchmt)       Date:  2012-06-12       Impact factor: 2.681

5.  Sustained partnership in primary care.

Authors:  N Leopold; J Cooper; C Clancy
Journal:  J Fam Pract       Date:  1996-02       Impact factor: 0.493

6.  Interest in over-the-counter access to oral contraceptives among women in the United States.

Authors:  Daniel Grossman; Kate Grindlay; Rick Li; Joseph E Potter; James Trussell; Kelly Blanchard
Journal:  Contraception       Date:  2013-04-23       Impact factor: 3.375

7.  Prescription Birth Control Access Among U.S. Women at Risk of Unintended Pregnancy.

Authors:  Kate Grindlay; Daniel Grossman
Journal:  J Womens Health (Larchmt)       Date:  2015-12-14       Impact factor: 2.681

8.  Accuracy of self-screening for contraindications to combined oral contraceptive use.

Authors:  Daniel Grossman; Leticia Fernandez; Kristine Hopkins; Jon Amastae; Sandra G Garcia; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2008-09       Impact factor: 7.661

9.  Benefits and risks of hormonal contraception for women.

Authors:  Vitali Gorenoi; Matthias P Schönermark; Anja Hagen
Journal:  GMS Health Technol Assess       Date:  2007-08-10

10.  Depression, diabetes, and chronic disease risk factors among US women of reproductive age.

Authors:  Sherry L Farr; Donald K Hayes; Rebecca H Bitsko; Pooja Bansil; Patricia M Dietz
Journal:  Prev Chronic Dis       Date:  2011-10-17       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.